PIMTARGA Trademark

Trademark Overview

On Tuesday, November 26, 2013, a trademark application was filed for PIMTARGA with the United States Patent and Trademark Office. The USPTO has given the PIMTARGA trademark a serial number of 86129277. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 8, 2024. This trademark is owned by GlaxoSmithKline LLC. The PIMTARGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
pimtarga

General Information

Serial Number86129277
Word MarkPIMTARGA
Filing DateTuesday, November 26, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 8, 2024
Registration Number5268642
Registration DateTuesday, August 22, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWilmington 19808
GB
Party NameGlaxoSmithKline LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808
Party NameGlaxoSmithKline LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Trademark Events

Event DateEvent Description
Friday, March 8, 2024CANCELLED SEC. 8 (6-YR)
Friday, September 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 22, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 14, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 14, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 22, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 6, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 28, 2017CASE RETURNED TO EXAMINATION
Monday, April 10, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, April 28, 2017ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Friday, April 28, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, April 26, 2017ASSIGNED TO PETITION STAFF
Friday, April 7, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, October 4, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 3, 2016SOU EXTENSION 5 GRANTED
Friday, September 30, 2016SOU EXTENSION 5 FILED
Friday, September 30, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 1, 2016SOU EXTENSION 4 GRANTED
Thursday, March 31, 2016SOU EXTENSION 4 FILED
Thursday, March 31, 2016SOU TEAS EXTENSION RECEIVED
Friday, September 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2015SOU EXTENSION 3 GRANTED
Tuesday, September 8, 2015SOU EXTENSION 3 FILED
Tuesday, September 8, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2015SOU EXTENSION 2 GRANTED
Wednesday, April 8, 2015SOU EXTENSION 2 FILED
Tuesday, April 14, 2015NOTICE OF REVIVAL - E-MAILED
Tuesday, April 14, 2015SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 14, 2015PETITION TO REVIVE-GRANTED
Tuesday, April 14, 2015TEAS PETITION TO REVIVE RECEIVED
Tuesday, September 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 8, 2014SOU EXTENSION 1 GRANTED
Thursday, August 14, 2014SOU EXTENSION 1 FILED
Friday, September 5, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 14, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 8, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 2, 2014ASSIGNED TO LIE
Monday, December 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 30, 2013ASSIGNED TO EXAMINER
Tuesday, December 10, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 29, 2013NEW APPLICATION ENTERED

Related Keywords

pimtarga pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological